| Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients EN Baruch, I Youngster, G Ben-Betzalel, R Ortenberg, A Lahat, L Katz, ... Science 371 (6529), 602-609, 2021 | 1207 | 2021 |
| Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease H Abu-Sbeih, DM Faleck, B Ricciuti, RB Mendelsohn, AR Naqash, ... Journal of Clinical Oncology 38 (6), 576-583, 2020 | 176 | 2020 |
| Real world outcomes of ipilimumab and nivolumab in patients with metastatic melanoma N Asher, G Ben-Betzalel, S Lev-Ari, R Shapira-Frommer, ... Cancers 12 (8), 2329, 2020 | 60 | 2020 |
| Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patients G Ben-Betzalel, Y Steinberg-Silman, R Stoff, N Asher, R Shapira-Frommer, ... European Journal of Cancer 108, 61-68, 2019 | 56 | 2019 |
| Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy A Nissani, S Lev-Ari, T Meirson, E Jacoby, N Asher, G Ben-Betzalel, ... Journal for Immunotherapy of Cancer 9 (5), e001743, 2021 | 48 | 2021 |
| Clinical significance of pancreatic atrophy induced by immune-checkpoint inhibitors: a case–control study Y Eshet, EN Baruch, R Shapira-Frommer, Y Steinberg-Silman, ... Cancer Immunology Research 6 (12), 1453-1458, 2018 | 48 | 2018 |
| Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600–mutant metastatic melanoma G Ben-Betzalel, EN Baruch, B Boursi, Y Steinberg-Silman, N Asher, ... European Journal of Cancer 101, 229-235, 2018 | 47 | 2018 |
| Recurrent pneumonitis in patients with melanoma treated with immune checkpoint inhibitors N Asher, EM Marom, G Ben‐Betzalel, EN Baruch, Y Steinberg‐Silman, ... The Oncologist 24 (5), 640-647, 2019 | 41 | 2019 |
| Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response MJ Besser, O Itzhaki, G Ben‐Betzalel, DB Zippel, D Zikich, A Kubi, ... Molecular carcinogenesis 59 (7), 736-744, 2020 | 28 | 2020 |
| Immunotherapy discontinuation in metastatic melanoma: lessons from real-life clinical experience N Asher, N Israeli-Weller, R Shapira-Frommer, G Ben-Betzalel, ... Cancers 13 (12), 3074, 2021 | 26 | 2021 |
| TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma J Roszik, E Markovits, P Dobosz, A Layani, K Slabodnik-Kaner, ... Cancer Immunology, Immunotherapy 68, 1493-1500, 2019 | 23 | 2019 |
| Abstract CT042: fecal microbiota transplantation (FMT) and re-induction of anti-PD-1 therapy in refractory metastatic melanoma patients-preliminary results from a phase I … EN Baruch, I Youngster, R Ortenberg, G Ben-Betzalel, LH Katz, A Lahat, ... Cancer Research 79 (13_Supplement), CT042-CT042, 2019 | 19 | 2019 |
| Perioperative BRAF inhibitors in locally advanced stage III melanoma D Zippel, G Markel, R Shapira‐Frommer, G Ben‐Betzalel, D Goitein, ... Journal of surgical oncology 116 (7), 856-861, 2017 | 16 | 2017 |
| Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach S Grynberg, M Vered, R Shapira-Frommer, N Asher, G Ben-Betzalel, ... JNCI: Journal of the National Cancer Institute 116 (4), 539-546, 2024 | 12 | 2024 |
| Real world evidence of Lenvatinib+ anti PD-1 as an advanced line for metastatic melanoma R Stoff, N Asher, S Laks, Y Steinberg, J Schachter, R Shapira-Frommer, ... Frontiers in Oncology 13, 1180988, 2023 | 12 | 2023 |
| Clinical significance of pancreatic atrophy induced by immune-checkpoint inhibitors: a case-control study. Cancer Immunol Res. 2018; 6 (12): 1453–1458. doi: 10.1158/2326-6066 Y Eshet, EN Baruch, R Shapira-Frommer, Y Steinberg-Silman, ... CIR-17-0659, 0 | 12 | |
| Better late than never: the impact of steroidal treatment on the outcome of melanoma patients treated with immunotherapy N Bar-Hai, G Ben-Betzalel, R Stoff, S Grynberg, J Schachter, ... Cancers 15 (11), 3041, 2023 | 11 | 2023 |
| Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients R Stoff, S Grynberg, N Asher, S Laks, Y Steinberg, J Schachter, ... Frontiers in Oncology 12, 1020058, 2022 | 11 | 2022 |
| Incidence and outcome of neurologic immune-related adverse events associated with immune checkpoint inhibitors in patients with melanoma J Pepys, R Stoff, R Ramon-Gonen, G Ben-Betzalel, S Grynberg, ... Neurology 101 (24), e2472-e2482, 2023 | 8 | 2023 |
| Radiotherapy may augment response to immunotherapy in metastatic uveal melanoma patients S Grynberg, R Stoff, N Asher, R Shapira-Frommer, J Schachter, ... Therapeutic Advances in Medical Oncology 14, 17588359221131521, 2022 | 7 | 2022 |
